mTOR Pathway Mutations and Response to Rapalogs in RCC-Letter.

Autor: Roldan-Romero JM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Rodríguez-Moreno JF; Genitourinary and Gynecological Cancer Unit, Clara Campal Comprehensive Cancer Center, Madrid, Spain.; Spanish Oncology GenitoUrinary Group (SOGUG), Spain., García-Donás J; Genitourinary and Gynecological Cancer Unit, Clara Campal Comprehensive Cancer Center, Madrid, Spain. crodriguez@cnio.es jgarciadonas@gmail.com.; Spanish Oncology GenitoUrinary Group (SOGUG), Spain., Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. crodriguez@cnio.es jgarciadonas@gmail.com.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Jazyk: angličtina
Zdroj: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Sep 01; Vol. 23 (17), pp. 5320.
DOI: 10.1158/1078-0432.CCR-17-1280
Databáze: MEDLINE